Effect of FK 506 on human hepatic cytochromes P-450: interaction with CyA.
Pichard
L
L
INSERM U128, Centre Paul Lamarque, Montpellier, France.
Fabre
I
I
Domergue
J
J
Joyeux
H
H
Maurel
P
P
D002478:Cells, Cultured; D016572:Cyclosporine / Q000378:metabolism* / Q000494:pharmacology; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis / Q000378:metabolism*; D004790:Enzyme Induction; D006801:Humans; D007527:Isoenzymes / Q000096:biosynthesis / Q000378:metabolism*; D008099:Liver / Q000201:enzymology*; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D010634:Phenobarbital / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D016559:Tacrolimus / Q000494:pharmacology*
D065607:Cytochrome P-450 Enzyme Inhibitors; D007527:Isoenzymes; D016572:Cyclosporine; D003577:Cytochrome P-450 Enzyme System; D012293:Rifampin; D016559:Tacrolimus; D010634:Phenobarbital